StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
PFT.AX$0.03-3.70%
Fair $0.03+0.0%

PFT.AX

Pure Foods Tasmania Limited

Consumer Defensive / Packaged FoodsASX

$0.03

-0.00 (-3.70%)

Fairly Valued+0.0%Fair Value $0.03Fund rank 33/100 · Data gapFallback financials|
SA 18/F
F-Score: 1/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 25%

FCF escenarios

weak_data · normalized FCF $-3.7M · quality 79.3/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 49/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

18/100

F

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years ROE is -46.2%, below the 5% threshold
Thesis & Journal · PFT.AXLocal privado en este navegador · Pure Foods Tasmania Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$9M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-46.2%

↓

Gross Margin

1.3%

↓

Debt/Equity

0.56

↑
52-Week Range$0
$0$0

TradingView lightweight chart

PFT.AX price, volumen y niveles de valoración

Último $0.026Periodo -100.0%
Fair value: $0.026

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

+0.5%

FCF CAGR

—

FCF margin

-38.1%

FCF / Net income

0.72x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $7.4M · net income $-3.9M · FCF $-2.8M

2021-FY → 2024-FY

Gross margin

1.3%-22.1% pts

Operating margin

-55.4%-37.1% pts

Net margin

-53.0%-43.2% pts

FCF margin

-38.1%+18.7% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$7.4M$7.4M$8.7M$9.9M$7.3M
Net Income$-3.9M$-3.9M$-1.8M$-3.3M$-716309.00
EBITDA$-3.9M$-3.9M$-1.2M$-3.3M$-451212.00
EPS-0.03-0.03-0.02-0.05-0.01
Gross Margin1.3%1.3%12.0%8.1%23.3%
Operating Margin-55.4%-55.4%-33.1%-41.8%-18.3%
Net Margin-53.0%-53.0%-20.9%-33.6%-9.8%
Balance Sheet
Debt/Equity0.560.560.370.150.30
Current Ratio0.510.51———
Cash Flow
Free Cash Flow$-2.8M$-2.8M$-3.7M$-5.8M$-4.2M
Returns
ROE-46.2%-46.2%-15.0%-28.4%-9.1%
Valuation
P/B0.370.371.141.094.52
Growth & Yield
Revenue Growth-14.9%-14.9%-11.9%35.2%—
EPS Growth-80.9%-80.9%63.8%-315.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +73.3%

Total return

+73.3%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.02 → -0.03

Residual

+73.3%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+73.3%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.